<DOC>
	<DOCNO>NCT00639769</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , irinotecan cisplatin , work different way stop growth tumor cell , either kill cell stop divide . Giving one drug ( combination chemotherapy ) may kill tumor cell . PURPOSE : To determine CPT-11 give together cisplatin effective treat recurrent metastatic head neck cancer .</brief_summary>
	<brief_title>Irinotecan Cisplatin Treating Patients With Recurrent Metastatic Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Evaluate efficacy irinotecan hydrochloride cisplatin patient local-regionally recurrent metastatic squamous cell carcinoma head neck . - Evaluate toxicity irinotecan hydrochloride cisplatin patient . - Determine palliative effect irinotecan hydrochloride cisplatin head neck cancer symptom use Vanderbilt Cancer Center ( VICC ) Head Neck Cancer Symptom Survey . OUTLINE : Patients receive irinotecan hydrochloride IV 60 minute cisplatin IV day 1 , 8 , 22 , 29 . Treatment repeat every 6 week 6 course absence disease progression unacceptable toxicity . Patients complete Vanderbilt Cancer Center ( VICC ) Head Neck Cancer Symptom Survey baseline , course , completion study therapy , follow-up visit . After completion study therapy , patient follow every 6 week 1 year every 3 month thereafter .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>Histologically confirm squamous cell carcinoma head neck consider incurable surgery radiotherapy Meets one follow criterion : Previously untreated disease Newly diagnose disease distant metastases Recurrent persistent disease Localregional recurrence/persistence distant metastases initial treatment surgery radiotherapy No locally advance unresectable disease previously treat radiotherapy Bidimensionally measurable disease If measurable disease within radiotherapy port , must biopsyproven recurrence ≥ 8 week completion radiotherapy PATIENT CHARACTERISTICS : ECOG performance status 02 Life expectancy ≥ 12 week Creatinine clearance ≥ 50 mL/min SGOT ≤ 3 time upper limit normal Serum bilirubin &lt; 1.5 mg/dL Granulocytes ≥ 1,500/mm ^3 Platelet count &gt; 100,000/mm^3 Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No significant detectable infection No comorbid disease unless adequate control No cancer within past 3 year except basal cell squamous cell skin cancer earlystage prostate cancer Pregnant lactate woman Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics Recovered prior major surgery No prior chemotherapy recurrent metastatic disease Patients complete neoadjuvant , concurrent , adjuvant chemotherapy ≥ 3 month prior recurrence consider chemotherapynaive Patients complete neoadjuvant , concurrent , adjuvant chemotherapy &lt; 3 month prior recurrence consider chemotherapy failures No prior therapy topotecan irinotecan hydrochloride At least 4 week since prior biologic therapy ( e.g. , interleukin2 , interferon , megestrol acetate )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV verrucous carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent verrucous carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent verrucous carcinoma oral cavity</keyword>
	<keyword>stage IV verrucous carcinoma oral cavity</keyword>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>untreated metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>salivary gland squamous cell carcinoma</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
</DOC>